Načítá se...
A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials
Historically, phase II oncology trials assessed a treatment’s efficacy by examining its tumor response rate in a single-arm trial. Then, approximately 25 years ago, certain statistical and pharmacological considerations ignited a debate around whether randomized designs should be used instead. Here,...
Uloženo v:
| Vydáno v: | J Natl Cancer Inst |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6910171/ https://ncbi.nlm.nih.gov/pubmed/31218346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz126 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|